SIGNATI, LORENA
SIGNATI, LORENA
Dipartimento di Scienze Biomediche e Cliniche
PATIENT-DERIVED ORGANOIDS AND EXTRACELLULAR VESICLES: UNLOCKING NEW FRONTIERS IN BREAST CANCER DRUG TESTING AND BIOMARKER DISCOVERY
2025 L. Signati
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
2024 S. Mazzucchelli, L. Signati, L. Messa, A. Franceschini, A. Bonizzi, L. Castagnoli, P. Gasparini, C. Consolandi, E. Mangano, P. Pelucchi, I. Cifola, T. Camboni, M. Severgnini, L. Villani, B. Tagliaferri, S. Carelli, S.M. Pupa, C. Cereda, F. Corsi
Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy
2024 M. Sevieri, F. Andreata, F. Mainini, L. Signati, F. Piccotti, M. Truffi, A. Bonizzi, L. Sitia, C. Pigliacelli, C. Morasso, B. Tagliaferri, F. Corsi, S. Mazzucchelli
HER-2-targeted nanoparticles for breast cancer diagnosis and treatment
2022 L. Sitia, M. Sevieri, L. Signati, A. Bonizzi, A. Chesi, F. Mainini, F. Corsi, S. Mazzucchelli
Lipofilling in breast oncological surgery : a safe opportunity or risk for cancer recurrence?
2021 F. Piccotti, I. Rybinska, E. Scoccia, C. Morasso, A. Ricciardi, L. Signati, T. Triulzi, F. Corsi, M. Truffi
Ultrastructural analysis of breast cancer patient-derived organoids
2021 L. Signati, R. Allevi, F. Piccotti, S. Albasini, L. Villani, M. Sevieri, A. Bonizzi, F. Corsi, S. Mazzucchelli